Health Catalyst, Inc. (HCAT)

Market Cap	319.46M
Revenue (ttm)	306.58M
Net Income (ttm)	-69.50M
Shares Out	70.21M
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	15.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	853,700
Open	4.560
Previous Close	4.600
Day's Range	4.335 - 4.600
52-Week Range	3.760 - 9.240
Beta	1.41
Analysts	Buy
Price Target	9.27 (+103.74%)
Earnings Date	May 8, 2025

About HCAT

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operat...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 25, 2019
• Employees: 1,500
• Stock Exchange: NASDAQ
• Ticker Symbol: HCAT
• Website: https://www.healthcatalyst.com

Financial Performance

In 2024, Health Catalyst's revenue was $306.58 million, an increase of 3.60% compared to the previous year's $295.94 million. Losses were -$69.50 million, -41.17% less than in 2023.

Analyst Forecast

According to 11 analysts, the average rating for HCAT stock is "Buy." The 12-month stock price forecast is $9.27, which is an increase of 103.74% from the latest price.

Price Target

$9.27

(103.74% upside)

Analyst Consensus: Buy